From hormone replacement therapy to regenerative scaffolds: A review of current and novel primary hypothyroidism therapeutics. (2022)
Attributed to:
UKRMP Hub: The Engineered Cell Environment.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fendo.2022.997288
PubMed Identifier: 36277721
Publication URI: http://europepmc.org/abstract/MED/36277721
Type: Journal Article/Review
Volume: 13
Parent Publication: Frontiers in endocrinology
ISSN: 1664-2392